title: Monoclonal antibodies to native HIV type 1 reverse transcriptase and their interaction with enzymes from different subtypes.
abstract: Recombinant reverse transcriptase (RT) from HIV-1 subtype B was used to produce mouse anti-RT monoclonal antibodies (MAbs). Immunization was done by mixing RT with the ISCOM matrix-forming adjuvant saponin (Quil A). Two different assays, both based on the interaction of native RT and antibodies, were used to monitor the immune response in mice and for screening, selection, and characterization of the MAbs. The first assay measures the capacity of antibodies to inhibit the polymerase activity of the RT and the second assay measures the ability of antibodies to capture enzymatically active RT. Twelve clones with the capacity to inhibit at least 50% of the RT activity and 34 clones with high RT-capturing capacity were found. The MAb panel was utilized to evaluate the immunological properties of 18 different RTs representing 9 different HIV1 subtypes. The RT-inhibitory MAbs could be divided into two groups based on their pattern of cross-reactivity toward the different HIV-1 RTs. The degree of diversity recorded among MAbs with RT-capturing capacity was larger. At least seven groups of MAbs with distinct cross-reactivity patterns were identified. Thus, the degree of isoenzyme specificity varied greatly, from MAbs that were quite specific for subtype B RT to one MAb that was able to capture the RTs from all HIV-1 isolates tested except one of the two group O isolates. In conclusion, our study revealed that there exist surprisingly large immunological differences between RTs from different HIV-1 subtypes as well as from the same subtype.
authors.affiliation: Unit of Medical Genetics, Department of Genetics and Pathology, Uppsala University, BMC, Sweden.
authors.forename: A S
authors.initials: AS
authors.lastname: Rytting
authors.forename: L
authors.initials: L
authors.lastname: Akerblom
authors.forename: J
authors.initials: J
authors.lastname: Albert
authors.forename: T
authors.initials: T
authors.lastname: Unge
authors.forename: E
authors.initials: E
authors.lastname: Björling
authors.forename: L
authors.initials: L
authors.lastname: Al-Khalili
authors.forename: J S
authors.initials: JS
authors.lastname: Gronowitz
authors.forename: C F
authors.initials: CF
authors.lastname: Källander
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000096:biosynthesis / Q000276:immunology*; D000918:Antibody Specificity; D018604:Epitope Mapping; D015483:HIV Antibodies / Q000097:blood; D015658:HIV Infections / Q000276:immunology / Q000821:virology; D054303:HIV Reverse Transcriptase / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D015497:HIV-1 / Q000145:classification* / Q000201:enzymology; D015498:HIV-2 / Q000145:classification* / Q000201:enzymology; D006801:Humans; D016882:ISCOMs / Q000276:immunology; D007114:Immunization; D051379:Mice; D011994:Recombinant Proteins / Q000276:immunology; D014776:Virus Cultivation
chemical_list: D000911:Antibodies, Monoclonal; D015483:HIV Antibodies; D016882:ISCOMs; D011994:Recombinant Proteins; D054303:HIV Reverse Transcriptase